IGF-1 helps regulate growth hormone levels, and vice versa (2)
You can minimize risks by only using facilities with qualified healthcare professionals trained in IV therapy
Whether synergistic, additive, or independent effects are produced in vivo depends on the specific research model, tissue type, and application method questions that remain open in the published literature for this specific blend ratio

Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation

Efficacy of Glutathione for the Treatment of Nonalcoholic Fatty Liver Disease: An Open-Label, Single-Arm, Multicenter, Pilot Study. BMC Gastroenterology, vol